Therapeutic targeting of Neu1 sialidase with oseltamivir phosphate (Tamiflu®) disables cancer cell survival in human pancreatic cancer with acquired chemoresistance
Myron R. Szewczuk(Queen's University), Ronald J. Neufeld(Queen's University)
Cited by 59
Related Papers
Oseltamivir phosphate monotherapy ablates tumor neovascularization, growth, and metastasis in mouse model of human triple-negative breast adenocarcinoma
|Breast Cancer Targets and Therapy|2014|40
Transcriptional factor snail controls tumor neovascularization, growth and metastasis in mouse model of human ovarian carcinoma
|Clinical and Translational Medicine|2014|30
Sialylation facilitates self-assembly of 3D multicellular prostaspheres by using cyclo-RGDfK(TPP) peptide
|OncoTargets and Therapy|2017|16